These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 32652826

  • 1. Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA.
    Pang C, Wen L, Qin H, Zhu B, Lu X, Luo S.
    J Cell Mol Med; 2020 Aug; 24(15):8452-8465. PubMed ID: 32652826
    [Abstract] [Full Text] [Related]

  • 2. Farnesoid X receptor agonist attenuates subchondral bone osteoclast fusion and osteochondral pathologies of osteoarthritis via suppressing JNK1/2/NFATc1 pathway.
    Hu W, Cai C, Li Y, Kang F, Chu T, Dong S.
    FASEB J; 2022 Apr; 36(4):e22243. PubMed ID: 35224782
    [Abstract] [Full Text] [Related]

  • 3. Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis.
    Ding D, Yan J, Feng G, Zhou Y, Ma L, Jin Q.
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34738623
    [Abstract] [Full Text] [Related]

  • 4. Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation.
    Bertuglia A, Lacourt M, Girard C, Beauchamp G, Richard H, Laverty S.
    Osteoarthritis Cartilage; 2016 Mar; 24(3):555-66. PubMed ID: 26505663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
    Dong Y, Liu H, Zhang X, Xu F, Qin L, Cheng P, Huang H, Guo F, Yang Q, Chen A.
    Int J Mol Sci; 2016 Jun 16; 17(6):. PubMed ID: 27322244
    [Abstract] [Full Text] [Related]

  • 7. Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.
    Cui Z, Crane J, Xie H, Jin X, Zhen G, Li C, Xie L, Wang L, Bian Q, Qiu T, Wan M, Xie M, Ding S, Yu B, Cao X.
    Ann Rheum Dis; 2016 Sep 16; 75(9):1714-21. PubMed ID: 26470720
    [Abstract] [Full Text] [Related]

  • 8. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.
    Siebelt M, Waarsing JH, Groen HC, Müller C, Koelewijn SJ, de Blois E, Verhaar JA, de Jong M, Weinans H.
    Bone; 2014 Sep 16; 66():163-70. PubMed ID: 24933343
    [Abstract] [Full Text] [Related]

  • 9. PD0325901, an ERK inhibitor, attenuates RANKL-induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathways.
    Jiang T, Gong Y, Zhang W, Qiu J, Zheng X, Li Z, Yang G, Hong Z.
    Bioorg Chem; 2023 Mar 16; 132():106321. PubMed ID: 36642020
    [Abstract] [Full Text] [Related]

  • 10. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.
    Guo H, Ding D, Wang L, Yan J, Ma L, Jin Q.
    PLoS One; 2021 Mar 16; 16(12):e0261127. PubMed ID: 34914744
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption.
    Ding D, Wang L, Yan J, Zhou Y, Feng G, Ma L, Yang Y, Pei X, Jin Q.
    PLoS One; 2022 Mar 16; 17(7):e0271485. PubMed ID: 35900969
    [Abstract] [Full Text] [Related]

  • 14. Amentoflavone maintaining extracellular matrix homeostasis and inhibiting subchondral bone loss in osteoarthritis by inhibiting ERK, JNK and NF-κB signaling pathways.
    Liang J, Hu J, Hong X, Zhou M, Xia G, Hu L, Luo S, Quan K, Yan J, Wang S, Fan S.
    J Orthop Surg Res; 2024 Oct 15; 19(1):662. PubMed ID: 39407273
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion.
    Fang C, Guo JW, Wang YJ, Li XQ, Zhang H, Cui J, Hu Y, Jing YY, Chen X, Su JC.
    Acta Pharmacol Sin; 2022 May 15; 43(5):1299-1310. PubMed ID: 34381182
    [Abstract] [Full Text] [Related]

  • 17. Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues.
    Chen W, Wang Q, Tao H, Lu L, Zhou J, Wang Q, Huang W, Yang X.
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr 25; 56(4):499-512. PubMed ID: 38439665
    [Abstract] [Full Text] [Related]

  • 18. Curcumin alleviates osteoarthritis in mice by suppressing osteoclastogenesis in subchondral bone via inhibiting NF-κB/JNK signaling pathway.
    Ding D, Liu G, Yan J, Zhang Q, Meng F, Wang L.
    PLoS One; 2024 Apr 25; 19(9):e0309807. PubMed ID: 39236007
    [Abstract] [Full Text] [Related]

  • 19. IgSF11 deficiency alleviates osteoarthritis in mice by suppressing early subchondral bone changes.
    Kim GM, Kim J, Lee JY, Park MC, Lee SY.
    Exp Mol Med; 2023 Dec 25; 55(12):2576-2585. PubMed ID: 38036734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.